REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07318597 updates: 1. start date: 2026-04-30 → 2026-05-06 2. completion date: 2028-09-27 → 2028-09-17 3. primary completion date: 2028-03-08 → 2028-02-27 4. enrollment: not set → 99 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical